News 15 jun 2022 Bernese start-up AlveoliX wins the Swiss Medtech Award 2022 On the occasion of the 2022 edition of the Swiss Medtech Day, AlveoliX won the highly coveted award for its small-scale replica of the human lung...
News 03 mai 2022 Why Switzerland’s pioneering role in blockchain combined with its biotech heritage makes it a source of innovation With the rise of new technologies such as blockchain and AI, the pragmatic regulatory approach of the Swiss authorities has become an important a...
ニュース 16 abr 2020 スイス・イノベーション ‐ 世界のアイデアをつなぐ場所 - スイス外国企業誘致局は、2020年よりスイスでイノベーション推進を行う財団「スイス・イノベーション(Switzerland Innovation)」のプロモーション活動を正式に開始いたしました。
News 31 mai 2022 RetinAI enters a multi-year software license agreement with Novartis Building on their existing relationship, Bern-based RetinAI and pharma giant Novartis have entered a long-term collaboration with a multi-year so...
News 04 mai 2022 Engimmune Therapeutics banks 15.5 million Swiss francs Engimmune Therapeutics will now be in a position to drive forward its innovative platforms for the development of T-cell therapies against cancer...
News 11 mai 2022 Eurostars grants CEIDOS and Limula EUR 1.14 million for an innovative device In collaboration with Limula, Valais-based CEIDOS has received a grant of EUR 1.14 million from Eurostars to develop a platform dedicated to the ...
Industry Report 28 fev 2022 Pakistan’s Medtech and digital health market With a roughly 220 million population Pakistan has a growing healthcare market, thanks to rapid urbanization, rising middle class and increasing ...
News 10 mai 2022 Michael J. Fox Foundation awards Asceneuron a grant to treat Parkinson’s disease Committed to accelerating research into novel Parkinson’s Disease therapies, The Michael J. Fox Foundation for Parkinson’s Research is again awar...
News 22 fev 2022 Digital neurotherapeutics specialist MindMaze secures USD 105 million MindMaze has closed a USD 105 million financing round to accelerate its global commercial growth plans, supercharge ongoing R&D and consolidate t...
News 02 mar 2022 Vaccines unique to each patient and cancer are being tested at the CHUV Two clinical trials on anti-cancer vaccines have just started at the Lausanne University Hospital (CHUV). Their groundbreaking nature could revol...
News 15 mar 2022 Leman Biotech raises USD 11 million for its immunotherapy boosting protein EPFL spin-off Leman Biotech has raised USD 11 million for its protein that can improve the effectiveness of immunotherapy drugs used to treat som...
News 01 fev 2022 Merck acquires Geneva-based biopharmaceutical company Chord Therapeutics Chord Therapeutics, a clinical stage biopharmaceutical company developing drugs for rare neuroinflammatory diseases, is being acquired by Merck.
News 12 jan 2022 ObsEva achieves positive results in the treatment of endometriosis Geneva-based women’s health biopharmaceutical company ObsEva has announced positive topline results from the Phase 3 EDELWEISS 3 trial of linzago...
News 20 jul 2021 World’s first hybrid robotic surgery took place at the Inselspital in Bern The Inselspital in Bern made history with the first clinical use of Distalmotion’s Dexter surgical robot in gynecology.
S-GE Event Tomorrow's Health: Meet the Experts on Patient Data, Empowerment & Blockchain 17 jun 2021 17 jun 2021 Suíça